Morgan Stanley Aqua Bounty Technologies, Inc. Transaction History

Morgan Stanley

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$0.22 - $0.4 $11,692 - $21,259	-53,148 Reduced 59.46%	36,234 $8,000
Q2 2023 Aug 14, 2023	SELL	$0.35 - $0.6 $18,072 - $30,981	-51,635 Reduced 36.62%	89,382 $32,000
Q1 2023 May 15, 2023	BUY	$0.55 - $1.17 $5,057 - $10,758	9,195 Added 6.98%	141,017 $84,000
Q4 2022 Feb 14, 2023	SELL	$0.6 - $17.32 $64,411 - $1.86 Million	-107,353 Reduced 44.88%	131,822 $100,000
Q3 2022 Nov 14, 2022	SELL	$0.8 - $15.88 $406,247 - $8.06 Million	-507,809 Reduced 67.98%	239,175 $187,000
Q2 2022 Oct 27, 2022	SELL	$1.18 - $2.04 $104,722 - $181,045	-88,748 Reduced 10.62%	746,984 $1.28 Million
Q2 2022 Aug 15, 2022	SELL	$1.18 - $2.04 $104,722 - $181,045	-88,748 Reduced 10.62%	746,984 $1.28 Million
Q1 2022 Oct 27, 2022	BUY	$1.34 - $2.26 $118,922 - $200,570	88,748 Added 11.88%	835,732 $1.56 Million
Q1 2022 May 13, 2022	SELL	$1.34 - $2.26 $533,289 - $899,428	-397,977 Reduced 32.26%	835,732 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$2.1 - $4.36 $1.77 Million - $3.68 Million	844,814 Added 217.23%	1,233,709 $2.59 Million
Q3 2021 Nov 15, 2021	BUY	$3.9 - $5.67 $1.52 Million - $2.21 Million	388,895 New	388,895 $1.58 Million

5.32M

Ticker AQB
Exchange NASDAQ
Sector Consumer Defensive
Industry Farm Products
Shares Outstandng 71,110,704
Market Cap $84.6M
Description
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sel...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.